Antimicrobial Activity of Brilacidin against E. coli
ACS Infectious Diseases · 2025
DOI: 10.1021/acsinfecdis.5c00023 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Infectious Diseases, 2025. Verfasst von Michael J Wilhelm und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and the Institute for Membranes and Interfaces, Temple University, Philadelphia, Pennsylvania 19122, United States. Hauptthemen laut MEDLINE: Escherichia coli, Anti-Bacterial Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: Division of Chemistry, National Institutes of Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and the Institute for Membranes and Interfaces, Temple University, Philadelphia, Pennsylvania 19122, United States.
- Department of Pharmaceutical Chemistry and the Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California 94143, United States.
ORCID-Profile: Michael J Wilhelm, Mohammad Sharifian Gh, William F DeGrado, Hai-Lung Dai
Förderung
- Division of Chemistry
- National Institutes of Health
Zitieren
APA
Wilhelm, M. J., Sharifian Gh, M., Mensa, B., Howell, G. L., DeGrado, W. F., & Dai, H. L. (2025). Antimicrobial Activity of Brilacidin against E. coli. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.5c00023
Vancouver
Wilhelm MJ, Sharifian Gh M, Mensa B, Howell GL, DeGrado WF, Dai HL. Antimicrobial Activity of Brilacidin against E. coli. ACS Infectious Diseases. 2025. doi:10.1021/acsinfecdis.5c00023
BibTeX
@article{Wilhelm2025,
author = {Wilhelm, Michael J and Sharifian Gh, Mohammad and Mensa, Bruk and Howell, Gabriella L and DeGrado, William F and Dai, Hai-Lung},
title = {Antimicrobial Activity of Brilacidin against E. coli},
journal = {ACS Infectious Diseases},
year = {2025},
doi = {10.1021/acsinfecdis.5c00023}
}
EUVIMED